Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

SHA:600721 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	62.56	298.65	272.05	202.07	135.73	86.88
Trading Asset Securities	201.98	-	-	-	-	-
Cash & Short-Term Investments	264.55	298.65	272.05	202.07	135.73	86.88
Cash Growth	4.22%	9.78%	34.63%	48.88%	56.22%	56.22%
Accounts Receivable	219.85	229.06	202.04	217.65	204.24	167.04
Other Receivables	3.2	5.03	6.45	6.18	3.95	7.94
Receivables	223.04	234.09	208.48	223.82	208.19	174.98
Inventory	27.22	30.36	99.72	124.83	149.43	194.05
Other Current Assets	8.89	2.31	3.02	14.04	12.32	12.18
Total Current Assets	523.7	565.41	583.27	564.77	505.67	468.09
Property, Plant & Equipment	135.55	138.27	140.11	138.19	147.8	161.64
Long-Term Investments	66.18	55.15	63.77	63.7	60.74	58.51
Goodwill	11.49	11.49	11.49	11.49	11.49	11.49
Other Intangible Assets	6.24	6.59	8.41	10.07	11.49	11.67
Long-Term Deferred Tax Assets	34.68	34.84	31.78	14.82	15.4	14.94
Long-Term Deferred Charges	37.88	37.13	30.19	13.47	4.17	4.68
Other Long-Term Assets	249.42	248.69	245.53	245.51	244.93	251.29
Total Assets	1,065	1,098	1,115	1,062	1,002	982.31

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	53.84	56.81	86.65	100.73	92.82	58.39
Accrued Expenses	19.25	26.57	29.57	29.15	26.8	25.18
Short-Term Debt	-	-	-	-	-	6.3
Current Portion of Leases	-	-	0.1	0.44	0.51	-
Current Income Taxes Payable	2.39	2.08	1.78	1.45	1.22	1.17
Current Unearned Revenue	97.61	110.13	140.51	111.27	98.85	85.73
Other Current Liabilities	41.99	51.25	50.51	65.4	69	77.11
Total Current Liabilities	215.07	246.84	309.12	308.44	289.2	253.89
Long-Term Leases	-	-	-	1.13	1.82	-
Long-Term Unearned Revenue	0.78	1.3	1.06	1.81	2.35	3.02
Pension & Post-Retirement Benefits	-	0.96	1.16	0.83	0.99	0.88
Long-Term Deferred Tax Liabilities	46.52	45.47	43.52	42.09	39.8	36.88
Other Long-Term Liabilities	2.11	1.16	1.1	1.1	0.5	1.39
Total Liabilities	264.47	295.73	355.96	355.39	334.66	296.06

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	384.55	384.55	384.03	381.69	377.67	375.13
Additional Paid-In Capital	361.78	362.34	2,266	2,258	2,235	2,217
Retained Earnings	47.1	47.72	-1,898	-1,940	-1,953	-1,918
Comprehensive Income & Other	7.24	7.24	7.2	7.29	7.43	7.66
Total Common Equity	800.66	801.84	758.58	706.62	667.01	681.3
Minority Interest	-	-	-	-	-	4.95
Shareholders' Equity	800.66	801.84	758.58	706.62	667.01	686.25
Total Liabilities & Equity	1,065	1,098	1,115	1,062	1,002	982.31

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	0.1	1.57	2.33	6.3
Net Cash (Debt)	264.55	298.65	271.95	200.5	133.4	80.59
Net Cash Growth	4.22%	9.82%	35.64%	50.29%	65.54%	44.90%
Net Cash Per Share	0.69	0.78	0.71	0.53	0.35	0.21
Filing Date Shares Outstanding	384.79	384.55	384.03	381.69	377.67	375.13
Total Common Shares Outstanding	384.79	384.55	384.03	381.69	377.67	375.13
Working Capital	308.63	318.57	274.15	256.33	216.47	214.21
Book Value Per Share	2.08	2.09	1.98	1.85	1.77	1.82
Tangible Book Value	782.94	783.76	738.68	685.06	644.04	658.14
Tangible Book Value Per Share	2.03	2.04	1.92	1.79	1.71	1.75
Buildings	-	161.92	161.92	161.92	161.73	158.52
Machinery	-	185.39	174.08	158.62	150.41	146.97

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error